| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/11/2005 | CN1613870A Tetramer combined with SARS antigen peptide and its preparation and use |
| 05/11/2005 | CN1200947C Method for producing cyclo-(Asp-Dphe-NMeVal-Arg-Gly) |
| 05/10/2005 | US6891021 Regulated apoptosis |
| 05/10/2005 | US6890896 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/10/2005 | US6890722 HP biopolymer markers predictive of insulin resistance |
| 05/10/2005 | US6890537 Antigrowth agents; microbiocides, bactericides |
| 05/10/2005 | US6890516 Identifying a substance capable of affecting long term memory in an animal comprising the determination that said substance alters activator homodimer, activator-repressor heterodimer and/ or repressor homodimer formation from normal |
| 05/06/2005 | WO2005040802A2 Cylin binding peptides, and their use in drug screening assays |
| 05/06/2005 | WO2005040799A1 Artificial antibody comprising complementary peptide |
| 05/06/2005 | WO2005040193A2 Synthetic peptides that cause f-actin bundling and block actin depolymerization |
| 05/06/2005 | WO2005039617A1 Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase u is beneficial, novel anabaenopeptin derivatives and intermediates thereof |
| 05/06/2005 | WO2005039616A1 Angiogenic peptides and uses thereof |
| 05/06/2005 | WO2005039613A1 Lim2 inhibitor of lm02 |
| 05/06/2005 | WO2005023834A3 Peptides and compounds that bind to thrombopoietin receptors |
| 05/06/2005 | WO2005019448A3 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 05/06/2005 | WO2004078933A3 Intracellular delivery of small molecules proteins and nucleic acids |
| 05/06/2005 | WO2003018606A3 Casein derived peptides and uses thereof in therapy |
| 05/06/2005 | WO2002095007A3 Conjugates activated by cell surface proteases and therapeutic uses thereof |
| 05/06/2005 | CA2543630A1 Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase u is beneficial, novel anabaenopeptin derivatives and intermediates thereof |
| 05/06/2005 | CA2542922A1 Protein expression |
| 05/05/2005 | US20050096457 Peptide substrates and fusion polypeptide substrates comprising a beta -secretase cleavage site wherein a human Aspartyl protease cleaves the peptide between P1 and P1, the rate of which cleavage is used to identify modulators of Alzeimer's disease, neurofibrillary tangles, gliosis and neuronal loss |
| 05/05/2005 | US20050095675 Mucin peptide with immunoenhancing properties |
| 05/05/2005 | US20050095652 Solid support comprising immobilized biopolymers for use as assay in monitoring receptor ligand interaction; drug screening; antibodiy sensitivity |
| 05/05/2005 | US20050095258 Vaccine inhibiting gonadotropin releasing hormone activity in cattle and protecting against bovine herpes virus type 1; polynucleotides, vectors, transformed cells |
| 05/05/2005 | US20050095243 Contacting the mixed population of cells with a BLyS(B lymphocte stimulator) antagonist and a CD20 antigen binding antibody; immunoadhesin; B cell neoplasm or a B-cell regulated autoimmune disorder |
| 05/05/2005 | US20050095241 Estrogen receptor modulators and uses thereof |
| 05/04/2005 | EP1527341A2 Interfacial biomaterials |
| 05/04/2005 | EP1527086A1 Compounds binding to p-selectin |
| 05/04/2005 | EP1506312A4 Metalloprotease peptide substrates and methods |
| 05/04/2005 | EP0781340B1 Vaccine against group A Streptococcal infection |
| 05/04/2005 | CN1612896A Peptide purification by means of metal ion affinity chromatography |
| 05/04/2005 | CN1612893A VEGF peptides and their use for inhibiting angiogenesis |
| 05/04/2005 | CN1612746A Use of HEPCIDIN as a regulator of iron homeostasis |
| 05/04/2005 | CN1200000C Cyclie somatostatin analogs |
| 05/04/2005 | CN1199988C Liquid-phase synthesis process of octrotide acetate |
| 05/04/2005 | CN1199986C Trivalent iron porphrin and its derivative-short peptide compound and its synthesis |
| 05/03/2005 | US6887847 Virus derived antimicrobial peptides |
| 05/03/2005 | US6887844 To stimulate the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM) |
| 05/03/2005 | US6887659 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 04/28/2005 | WO2005038000A2 T cell epitopes useful in mycobacterium tuberculosis vaccine and as diagnostic tools and methods for identifying same |
| 04/28/2005 | WO2005037862A1 Targeting compositions and preparation thereof |
| 04/28/2005 | WO2005037860A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/28/2005 | WO2005037859A2 Fluorescence assay for kinase activity |
| 04/28/2005 | WO2005037854A2 Immunogenic peptides |
| 04/28/2005 | WO2005012348A3 Cyclic cadherin analogues comprising the sequence hav for modulating the migration of vascular smooth muscle cells |
| 04/28/2005 | WO2005003292A3 Composition and method for self-assembly and mineralization of peptide amphiphiles |
| 04/28/2005 | WO2004110390A3 Anti-cd74 immunoconjugates and methods |
| 04/28/2005 | WO2004011486A8 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| 04/28/2005 | WO2003092631A3 Cyclic peptide anti-viral agents and methods |
| 04/28/2005 | US20050090649 synthetic metalloproteins; either covalent or non-covalent, with biomolecules such as antibodies, antigens, enzymes, receptors, nucleic acids, peptides and proteins |
| 04/28/2005 | US20050090641 miniblock polymers that can self-assemble into three-dimensional materials through liquid crystalline behavior |
| 04/28/2005 | US20050090449 treating neurodegenerative diseases by administering drugs that inhibit beta-secretase-mediated cleavage of amyloid precursor proteins |
| 04/28/2005 | US20050090448 Peptides that inhibit complement activation |
| 04/28/2005 | US20050090446 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 04/28/2005 | US20050090432 Macrocyclic isoquinoline peptide inhibitors of Hepatitis C virus |
| 04/28/2005 | US20050090431 Water soluble prodrugs of hindered alcohols |
| 04/28/2005 | US20050089946 Bioassay; immunoassay; fluorescent dyes binds flexible peptide; self-quenching |
| 04/28/2005 | US20050089932 Novel proteins with targeted binding |
| 04/28/2005 | US20050089927 Novel peptides for the diagnosis of schizophrenia |
| 04/28/2005 | US20050089886 Host cell expression systems, proteins, fusion proteins, polypeptides and peptides, antibodies; genetically engineered animals; drug screening, diagnosis |
| 04/28/2005 | CA2542684A1 Targeting compositions and preparation thereof |
| 04/28/2005 | CA2542639A1 Novel heat shock protein 20-related polypeptides and uses therefor |
| 04/28/2005 | CA2541634A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/27/2005 | EP1526183A2 Dimer of a peptide derived from the C-terminal sequence of human superoxide dismutase facilitating the penetration of a substance into cells and/or cell nuclei |
| 04/27/2005 | EP1525481A2 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures |
| 04/27/2005 | EP1525479A1 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes |
| 04/27/2005 | EP1525218A1 Bicyclic oligopeptides and their use as glucagon receptor antagonists |
| 04/27/2005 | EP1525217A1 Plant peptide with antimicrobial activity |
| 04/27/2005 | EP1263778B1 Peptide inhibitors of lfa-1/icam-1 interaction |
| 04/27/2005 | CN1610831A Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same |
| 04/27/2005 | CN1198841C Method for preparing cyclic vasoactive peptide analogs |
| 04/27/2005 | CN1198837C Purification of tissue plasminogen activator (tPA) |
| 04/27/2005 | CN1198834C Water soluble produgs of hindered alcohols or phenols |
| 04/26/2005 | US6884878 Neuropeptides and their use for pest control |
| 04/26/2005 | US6884868 Cyclic hexapeptides having antibiotic activity |
| 04/26/2005 | US6884774 Cyclic hexapeptide derivatives |
| 04/21/2005 | WO2005035554A1 Dioxin-binding material and method of detecting or quantifying dioxin |
| 04/21/2005 | WO2005035550A2 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 04/21/2005 | WO2005035525A2 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/21/2005 | WO2005035003A2 Compositions and methods for increasing drug efficiency |
| 04/21/2005 | WO2005034982A1 Cyclic peptide antitumor agents |
| 04/21/2005 | WO2005023857A3 Agent derived from tortoise spleen stimulating mammalian hemopoiesis |
| 04/21/2005 | WO2004104594A3 Light emitting probes |
| 04/21/2005 | WO2004073649A3 Clk-peptide and slk-peptide |
| 04/21/2005 | WO2004056080A9 Endothelial cell specifically binding peptides |
| 04/21/2005 | WO2004018628A3 Charged peptide-amphiphile solutions & self-assembled peptide nanofiber networks formed therefrom |
| 04/21/2005 | US20050085623 Bioactive amino acid sequences conjugated with biocompatible, biodegradable delivery system for use in treatment and prevention of bone disorders: prosthetics |
| 04/21/2005 | US20050085425 Novel peptidomimetic NS3-serine protease inhibitors of hepatitis C virus |
| 04/21/2005 | US20050085421 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 04/21/2005 | US20050084857 Breast tumor antigen for use as tool in diagnosis prevention and treatment of mammary gland cell proliferative disorders; antitumor agents |
| 04/21/2005 | US20050084491 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases |
| 04/20/2005 | EP1523582A2 Rapid, efiicient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 04/20/2005 | EP1523495A2 Peptides for inducing apoptosis in tumor cells |
| 04/20/2005 | EP1523494A2 Beta-sheet forming peptides and material made thereof |
| 04/20/2005 | EP1523323A2 Reagents and methods for smooth muscle therapies |
| 04/20/2005 | EP1355920A4 Extractive purification of lipopeptide antibiotics |
| 04/20/2005 | EP1254161B1 Aerothricin analogs, their preparation and use |
| 04/20/2005 | EP1196184B1 Compositions for treatment of sexual dysfunction |
| 04/20/2005 | EP1175435B1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof |
| 04/20/2005 | EP1049481B1 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |